CTRI/2014/01/004363招募中3 期
A randomized controlled trial of neoadjuvant chemotherapy with interval cytoreduction vs primary cytoreduction in advanced (stage IIIc/IV) epithelial ovarian cancer
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Previously untreated patients with cytologically/histologically proven ovarian cancer showing peritoneal deposits outside the pelvis of >2cms either clinically/ radiologically
- •2.Patients with cytological/histologically proven ovarian cancer with regional lymph node metastasis
- •3.Patients with malignant pleural effusion confirmed to be of ovarian origin,
排除标准
- •1.Patients with early stage ovarian cancer and those with peritoneal deposits <2 cms.
- •2.Patients with distant metastasis except mentioned above.
- •3.Nonepithelial tumors of ovary such as germ cell tumor, sexcord stromal tumor etc.
- •4.Patients who have been previously treated or started treatment outside the institute or recurrent lesions will be excluded.
- •5.Patients with poor performance status or medical contraindications for chemotherapy and/or surgery will be excluded
研究者
相似试验
已完成
3 期
Randomized controlled trial of neoadjuvant chemotherapy plus surgery versus neoadjuvant chemoradiotherapy plus surgery in patients with clinical stage IIB-III esophageal carcinoma (Subset analyses depending on the REG I expression in the tumor)thoracic esophageal cancerJPRN-UMIN000004707The cancer board of esophageal cancer in Akita University Hospital150
已完成
1 期
eo-adjuvant Progesterone and Vitamin D3 in Breast cancerCTRI/2013/06/003788Tata Memorial Hospital800
已完成
不适用
A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervixCervix cancerMalignant neoplasm of cervix uteriCancerISRCTN52711596Cancer Research UK (CRUK) (UK)
进行中（未招募）
不适用
Clinical trial with or without chemotherapy after surgical resection of the primary lung cancer in patients with high risk of relapse based on the Pervenio? Lung RS AssayCompletely resected stage I non-squamous non-small cell lung cancer (NSCLC)MedDRA version: 14.1Level: LLTClassification code 10025044Term: Lung cancerSystem Organ Class: 100000004864EUCTR2013-001494-24-ESEncore Clinical, Inc1,050
进行中（未招募）
1 期
Clinical trial with or without chemotherapy after surgical resection of the primary lung cancer in patients with high or intermediate risk of relapse based on a 14-Gene Prognostic AssayCompletely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10029517Term: Non-small cell lung cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10029518Term: Non-small cell lung cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-001494-24-FRIFCT1,050